Policy Tracker · Patient Lens · July 15, 2026

One patient's lawsuit could test how Novo Nordisk priced Ozempic

The claims in Hill's case may shape whether more patients get their day in court over what they paid.

2 developments affecting GLP-1 access were tracked on Tuesday, July 14, 2026, across 1 category. Each entry links to the full record.

## Courts and enforcement

**[Patient sues Novo Nordisk over GLP-1 pricing and marketing](/lawsuits/cl-73622952)**.

**[Hill v. Novo Nordisk: Pending lawsuit details unclear](/lawsuits/cl-73619551)**.

By Amanda Bonello

Originally published by Patient Lens on GLP-1 Laws, operated by GLP-1 Studio LLC — a for-profit company founded by the Collective's Executive Director. Republished here in full, with permission, at no cost. The Collective pays nothing for it and receives no payment for publishing it. How this works.